Simcha Jong (MS&I) and Suzy Farid (UCL Biochemical Engineering) have organised a workshop on cell therapy commercialisation.
This specialist one day practical workshop on the topic of cell therapy process and business development will enable participants to work through a number of scenarios in a small group format to cover a range of toolsets developed within the Technology Strategy Board-funded British Regen Industry Tool Set (BRITS) project, with the aim of optimising future process development and business strategies for cell therapy manufacture and commercialisation.
The BRITS project has been focused on the commercialisation of cell therapy and regenerative medicine within the UK, and has had an emphasis on building a set of tools that have the ability to streamline cell therapy process development, manufacturing, business development, and regulatory strategies.
The project is a collaboration involving a number of project partners including UCL, Lonza, LGC, Future Medicine, LRMN, and the NHS Technology Adoption Centre, and was funded by the Technology Strategy Board under their Regenerative Medicine program: Value Systems and Business Modelling. The meeting is free of charge to attend and will take place on Tuesday 1st July 2014 from 9am onwards.
The agenda includes a Lonza cell therapy manufacturing overview from Dr. Kim Warren (Lonza, Inc., Walkersville, MD, US), a cell therapy bioprocess economics case study from Dr. Suzanne Farid & Dr. Sally Hassan (Advanced Centre for Biochemical Engineering, UCL) and a valuation and business planning tool for cell therapy projects from Dr. Simcha Jong (Department of Management Science & Innovation, UCL).
Jong, S. (2014). BRITS cell therapy business planning and valuation tool. [Digital scholarly resource]. Retrieved from http://blogs.ucl.ac.uk/brits/.